Journal: PLOS Biology
Article Title: Expression of intron-containing HIV-1 RNA induces NLRP1 inflammasome activation in myeloid cells
doi: 10.1371/journal.pbio.3003320
Figure Lengend Snippet: (A, B) Transient knockdown of AIM2, NLRP1, NLRP3, CARD8, CASP1, and CASP4 by siRNA transfection in primary MDMs. Knock-down efficiency was determined by RT-qPCR at day 2 post-transfection, and represented as relative mRNA expression of individual targets compared to scramble siControl (A) , and protein level analyzed by immunoblotting (B) . MDMs were infected with Lai∆envGFP/G (MOI 1) for 3 days in the absence (DMSO) or presence of EFV (C–G) . Culture supernatants were harvested at 3 dpi and analyzed for p24 Gag (C) , IL-1β (D) , and IP-10 (E) secretion by ELISA. (F) Bioactive type I IFN in the culture supernatants from infected MDMs at 3 dpi quantified using interferon bioassay. The values in panels B-E were normalized to that of siControl-transfected and HIV-1-infected cells in each donor and reported as relative expression. (G) Quantitation of LDH release in culture supernatants was measured using the CytoTox cytotoxicity assay, followed by subtraction of background OD from culture media, and normalized to EFV-treatment for each siRNA transduction per donor. The means ± SEM are shown, and each symbol represents an independent donor. Statistical significance was determined by two-way ANOVA followed by Dunnett’s post-test comparing HIV-infected MDMs from siControl to indicated specific siRNA (D, G) . P -values: **** < 0.0001; * < 0.05; no symbol: not significant ( p ≥ 0.05). The data underlying this figure can be found in .
Article Snippet: At day 2 post-transfection, cells were either infected with HIV-1 (as described above), or stimulated as follows to determine functional knockdown: AIM2 (cells were treated with ultra-pure LPS (100 ng/m, Invivogen) for 2 h, followed by transfection with linearized DNA (1 μg/mL) for 4 h); NLRP1 and CARD8 (cells were primed with Pam3CSK4 (0.5 μg/mL, InvivoGen) for 4 h, followed by stimulation with Val-boroPro (10 μM, InvivoGen) for 24 h; NLRP3 and caspase-1 (cells were primed with ATP (5 mM, Thermo Scientific) for 6 h, followed by activation with nigericin (10 μM) for 60 min; Caspase-4 (cells were transfected with ultra-pure LPS (5 μg/ml, InvivoGen) for 6 hrs; UNC93B1 (cells were treated with Resiquimod (5 μg/ml, Invivogen) for 24 h. At the indicated timepoints, culture supernatants were harvested for IL-1β and IP-10 ELISA, and cells were lysed for RNA or protein analysis.
Techniques: Knockdown, Transfection, Quantitative RT-PCR, Expressing, Western Blot, Infection, Enzyme-linked Immunosorbent Assay, Bioassay, Quantitation Assay, Cytotoxicity Assay, Transduction